Medifast (MED) Interest & Investment Income (2016 - 2026)

Medifast (MED) has 6 years of Interest & Investment Income data on file, last reported at $1.4 million in Q1 2026.

• Quarterly Interest & Investment Income rose 6.0% year-over-year to $1.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.5 million (up 6.25% YoY) and the FY2018 annual result came in at -$171000.0, down 6.88% from the prior year.
• Interest & Investment Income slipped to $1.4 million in Q1 2026, from $1.4 million in the prior quarter.
• In the past five years, Interest & Investment Income ranged from a high of $1.4 million in Q3 2025 to a low of $1.2 million in Q1 2024.
• A 3-year average of $1.3 million and a median of $1.3 million in 2024 frame the typical range for Interest & Investment Income.
• The widest YoY moves for Interest & Investment Income: up 6.98% in 2025, down 5.63% in 2025.
• Tracing MED's Interest & Investment Income over 3 years: stood at $1.3 million in 2024, then climbed by 6.98% to $1.4 million in 2025, then dropped by 3.3% to $1.4 million in 2026.
• The last three Interest & Investment Income figures came in at $1.4 million (Q1 2026), $1.4 million (Q3 2025), and $1.4 million (Q2 2025), per Business Quant data.